These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27840993)

  • 1. NTN4 is associated with breast cancer metastasis via regulation of EMT-related biomarkers.
    Xu X; Yan Q; Wang Y; Dong X
    Oncol Rep; 2017 Jan; 37(1):449-457. PubMed ID: 27840993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of MEK5 by Stat3 promotes breast cancer cell invasion and metastasis.
    Liu F; Zhang H; Song H
    Oncol Rep; 2017 Jan; 37(1):83-90. PubMed ID: 27878304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
    Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
    Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Netrin-4 as a biomarker promotes cell proliferation and invasion in gastric cancer.
    Lv B; Song C; Wu L; Zhang Q; Hou D; Chen P; Yu S; Wang Z; Chu Y; Zhang J; Yang D; Liu J
    Oncotarget; 2015; 6(12):9794-806. PubMed ID: 25909166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro.
    Xiao M; Yang S; Meng F; Qin Y; Yang Y; Jia S; Cai X; Li C; Huang Y; Ning X
    Cell Physiol Biochem; 2017; 41(3):1072-1082. PubMed ID: 28245476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
    Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
    Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
    Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying and targeting determinants of melanoma cellular invasion.
    Jayachandran A; Prithviraj P; Lo PH; Walkiewicz M; Anaka M; Woods BL; Tan B; Behren A; Cebon J; McKeown SJ
    Oncotarget; 2016 Jul; 7(27):41186-41202. PubMed ID: 27172792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.
    Shah P; Gau Y; Sabnis G
    Breast Cancer Res Treat; 2014 Jan; 143(1):99-111. PubMed ID: 24305977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
    Jin L; Chen J; Li L; Li C; Chen C; Li S
    Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of SDF-1 activates the NF-κB pathway to induce epithelial to mesenchymal transition and cancer stem cell-like phenotypes of breast cancer cells.
    Kong L; Guo S; Liu C; Zhao Y; Feng C; Liu Y; Wang T; Li C
    Int J Oncol; 2016 Mar; 48(3):1085-94. PubMed ID: 26782945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
    Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
    Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
    Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NR2F2 plays a major role in insulin-induced epithelial-mesenchymal transition in breast cancer cells.
    Xia B; Hou L; Kang H; Chang W; Liu Y; Zhang Y; Ding Y
    BMC Cancer; 2020 Jul; 20(1):626. PubMed ID: 32631390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of the mesenchymal to epithelial transition by demethylation- activated microRNA-200c is involved in the anti-migration/invasion effects of arsenic trioxide on human breast cancer cells.
    Si L; Jiang F; Li Y; Ye X; Mu J; Wang X; Ning S; Hu C; Li Z
    Mol Carcinog; 2015 Sep; 54(9):859-69. PubMed ID: 24729530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis.
    Cui B; Zhang S; Chen L; Yu J; Widhopf GF; Fecteau JF; Rassenti LZ; Kipps TJ
    Cancer Res; 2013 Jun; 73(12):3649-60. PubMed ID: 23771907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells.
    Lee Y; Jung WH; Koo JS
    Breast Cancer Res Treat; 2015 Sep; 153(2):323-35. PubMed ID: 26285644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.